Published in
Elsevier, Lung Cancer, 2(83), p. 219-223, 2014
DOI: 10.1016/j.lungcan.2013.11.020
Links
Tools
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer
Journal article published in 2014 by
Joe J. Stephenson,
John Nemunaitis,
Anil A. Joy,
Julie C. Martin,
Ying-Ming Jou,
Da Zhang,
Paul Statkevich,
Siu-Long Yao,
Yali Zhu,
Honghong Zhou,
Karen Small,
Rajat Bannerji 
,
Martin J. Edelman
,
Martin J. Edelman
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 